in 9 months of selling inhaler portfolio, 3 million $ This may be under target
anonymous Guest anonymous   Feb 01, 2018 at 06:51: PM #1 anonymous Guest in 9 months of selling inhaler portfolio, 3 million $ This may be under target
anonymous Guest anonymous   Feb 08, 2018 at 01:59: PM #2 anonymous Guest It’s a real shocker Novartis parted with these 11th to market game changers...
anonymous Guest anonymous   Feb 08, 2018 at 02:03: PM #3 anonymous Guest anonymous said: in 9 months of selling inhaler portfolio, 3 million $ This may be under target Click to expand... Litterally just curious, do you know how they plan to market Lonhala? How is it going?
anonymous said: in 9 months of selling inhaler portfolio, 3 million $ This may be under target Click to expand... Litterally just curious, do you know how they plan to market Lonhala? How is it going?
anonymous Guest anonymous   Feb 09, 2018 at 05:35: PM #4 anonymous Guest don't worry Timmy's got it....bahhahahahahahahahahahahaha
anonymous Guest anonymous   Mar 09, 2018 at 05:10: PM #5 anonymous Guest Ugh ya think? this cant last